TNL Mediagene Granted Continued Listing by Nasdaq Hearings Panel, Subject to Meeting $1 Bid Price Rule On or Before January 7, 2026

Core Viewpoint - TNL Mediagene has been granted a continuation of its listing on the Nasdaq Capital Market, contingent upon demonstrating compliance with the $1 Bid Price Rule by January 7, 2026 [1][2]. Group 1: Compliance and Listing Status - The Nasdaq Hearings Panel has allowed TNL Mediagene to remain listed on Nasdaq, provided the company meets the $1 Bid Price Rule by the specified date [1][2]. - The company must notify Nasdaq of any significant events that could impact its compliance during the exception period [1]. - A hearing was held on December 16, 2024, where the company presented its compliance plan, including a reverse share split announced on December 19, 2025 [2]. Group 2: Background and Company Information - TNL Mediagene was formed in May 2023 through the merger of The News Lens Co. from Taiwan and Mediagene Inc. from Japan, becoming a leading digital media group in Asia [4]. - The company operates across various media brands in Japanese, Chinese, and English, covering diverse topics such as news, business, technology, and lifestyle [4]. - TNL Mediagene employs approximately 500 staff across Asia, with offices in Japan, Taiwan, and Hong Kong [4].